UroGen Pharma Ltd. [•] Ordinary Shares (Par Value NIS 0.01 Per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • April 7th, 2017 • UroGen Pharma Ltd. • Pharmaceutical preparations • New York
LICENSE AGREEMENT between UroGen Pharma, Ltd. and Allergan Pharmaceuticals International Limited Dated as of October 7, 2016License Agreement • April 7th, 2017 • UroGen Pharma Ltd. • Pharmaceutical preparations
This License Agreement (this “Agreement”) is made and entered into as of October 7, 2016 (the “Effective Date”) by and between UroGen Pharma Ltd., a corporation organized under the laws of Israel (“UroGen”) and Allergan Pharmaceuticals International Limited, a corporation organized under the laws of Ireland (“Allergan”). UroGen and Allergan are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • April 7th, 2017 • UroGen Pharma Ltd. • Pharmaceutical preparations
THIS INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of September 18, 2014, by and among TheraCoat Ltd., a private company incorporated under the laws of the State of Israel of, 13 HaSadna St., P.O. Box 2397, Ra’anana 4365007, Israel (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
